Lincoln Pharmaceuticals Limited (BOM:531633)
India · Delayed Price · Currency is INR 618.75
-4.15 (-0.67%)
At close: Sep 4, 2026
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 12.39 billion as of September 4, 2026. Its market cap has increased by 11.04% in one year.
Market Cap
12.39B
Enterprise Value
10.03B
Revenue
6.94B
Ranking
n/a
PE Ratio
12.85
Stock Price
618.75
ChartMarket Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 12.39B, an increase of 8,822.22%. That is a compound annual growth rate of 22.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 12.39B | 28.05% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 22.58B |
| Syncom Formulations (India) | 19.33B |
| TTK Healthcare | 15.60B |
| Amrutanjan Health Care | 14.64B |
| Fermenta Biotech | 14.29B |
| Kopran | 11.20B |
| Bharat Parenterals | 10.53B |
| Sudarshan Pharma Industries | 9.49B |